{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T04:51:10Z","timestamp":1783227070918,"version":"3.54.6"},"reference-count":57,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1016\/j.ophtha.2006.11.008","type":"journal-article","created":{"date-parts":[[2007,1,26]],"date-time":"2007-01-26T12:43:38Z","timestamp":1169815418000},"page":"780-786.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":113,"title":["Longitudinal Study of the Ocular Complications of AIDS"],"prefix":"10.1016","volume":"114","author":[{"given":"Douglas A.","family":"Jabs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark L.","family":"Van Natta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet T.","family":"Holbrook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Kempen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Curtis L.","family":"Meinert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2006.11.008_bib1","first-page":"623","article-title":"Ocular manifestations of HIV infection","volume":"93","author":"Jabs","year":"1995","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.ophtha.2006.11.008_bib2","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/archopht.1996.01100140035004","article-title":"Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression","volume":"114","author":"Hoover","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.11.008_bib3","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/S0161-6420(94)31181-X","article-title":"Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial 4: visual outcomes","volume":"101","year":"1994","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2006.11.008_bib4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1001\/archopht.1996.01100130021004","article-title":"Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS: the Cytomegalovirus Retreatment Trial","volume":"114","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.11.008_bib5","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1001\/archopht.1997.01100160698006","article-title":"MSL-109 adjuvant therapy for cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: the Monoclonal Antibody Cytomegalovirus Retinitis Trial","volume":"115","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.11.008_bib6","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0002-9394(01)00840-6","article-title":"The ganciclovir implant plus oral ganciclovir versus parenteral cidofovir for the treatment of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: the Ganciclovir Cidofovir Retinitis Trial","volume":"131","year":"2001","journal-title":"Am J Ophthalmol"},{"issue":"RR-8","key":"10.1016\/j.ophtha.2006.11.008_bib7","first-page":"1","article-title":"Guidelines for preventing opportunistic infections among HIV-infected persons\u20142002","volume":"51","author":"Kaplan","year":"2002","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.ophtha.2006.11.008_bib8","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1093\/infdis\/168.6.1506","article-title":"Intravitreal ganciclovir concentration after intravenous administration in AIDS patients with cytomegalovirus retinitis: implications for therapy","volume":"168","author":"Kuppermann","year":"1993","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ophtha.2006.11.008_bib9","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/infdis\/172.4.951","article-title":"Intravitreous and plasma concentrations of ganciclovir and foscarnet after intravenous therapy in patients with AIDS and cytomegalovirus therapy in patients with AIDS and cytomegalovirus retinitis","volume":"172","author":"Arevalo","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ophtha.2006.11.008_bib10","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1001\/archopht.1994.01090240037023","article-title":"Treatment of cytomegalovirus retinitis with an intraocular sustained-release ganciclovir implant: a randomized controlled clinical trial","volume":"112","author":"Martin","year":"1994","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.11.008_bib11","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1056\/NEJM199904083401402","article-title":"Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant","volume":"340","author":"Martin","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ophtha.2006.11.008_bib12","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1056\/NEJM199201233260401","article-title":"Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis","volume":"326","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ophtha.2006.11.008_bib13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0002-9394(14)71645-9","article-title":"Rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis: the Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial","volume":"124","year":"1997","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.11.008_bib14","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1001\/archopht.118.9.1196","article-title":"Risk factors for advancement of cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome","volume":"118","author":"Holbrook","year":"2000","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.11.008_bib15","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ophtha.2006.11.008_bib16","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0002-9394(14)70789-5","article-title":"AIDS and ophthalmology: a period of transition","volume":"124","author":"Jabs","year":"1997","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.11.008_bib17","first-page":"1931","article-title":"Decline in the rate of specific opportunistic infections at San Francisco General Hospital, 1994\u20131997","volume":"12","author":"Holtzer","year":"1998","journal-title":"AIDS"},{"key":"10.1016\/j.ophtha.2006.11.008_bib18","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1086\/313612","article-title":"Natural history and outcome of new AIDS-related cytomegalovirus retinitis diagnosed in the era of highly active antiretroviral therapy","volume":"30","author":"Jacobson","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ophtha.2006.11.008_bib19","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1001\/archopht.122.7.1040","article-title":"AIDS and ophthalmology in 2004","volume":"122","author":"Jabs","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.11.008_bib20","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1038\/nm0898-953","article-title":"Restoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1","volume":"4","author":"Komanduri","year":"1998","journal-title":"Nat Med"},{"key":"10.1016\/j.ophtha.2006.11.008_bib21","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0002-9394(98)00285-2","article-title":"Discontinuing anticytomegalovirus therapy in patients with immune reconstitution after combination antiretroviral therapy","volume":"126","author":"Jabs","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.11.008_bib22","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1086\/517399","article-title":"Long-lasting remission of cytomegalovirus retinitis without maintenance therapy in human immunodeficiency virus-infected patients","volume":"177","author":"Tural","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ophtha.2006.11.008_bib23","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1086\/515281","article-title":"Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy","volume":"177","author":"Macdonald","year":"1998","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ophtha.2006.11.008_bib24","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1001\/jama.282.17.1633","article-title":"Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis","volume":"282","author":"Whitcup","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.ophtha.2006.11.008_bib25","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/00002030-200001280-00013","article-title":"CMV retinitis recurs after stopping treatment in virological and immunological failure of potent antiretroviral therapy","volume":"14","author":"Torriani","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/j.ophtha.2006.11.008_bib26","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1086\/319219","article-title":"Recurrences of cytomegalovirus retinitis in a human immunodeficiency virus-infected patient despite potent antiretroviral therapy and apparent immune reconstitution","volume":"32","author":"Johnson","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ophtha.2006.11.008_bib27","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1086\/319683","article-title":"Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis","volume":"183","author":"Komanduri","year":"2001","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ophtha.2006.11.008_bib28","doi-asserted-by":"crossref","first-page":"239","DOI":"10.7326\/0003-4819-137-4-200208200-00008","article-title":"Safe interruption of maintenance therapy against previous infection with four common HIV-associated opportunistic pathogens during potent antiretroviral therapy","volume":"137","author":"Kirk","year":"2002","journal-title":"Ann Intern Med"},{"issue":"RR-17","key":"10.1016\/j.ophtha.2006.11.008_bib29","first-page":"1","article-title":"1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults","volume":"41","year":"1992","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.ophtha.2006.11.008_bib30","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1001\/archopht.1996.01100140055008","article-title":"Measuring visual function and quality of life in patients with cytomegalovirus retinitis: development of a questionnaire","volume":"114","author":"Wu","year":"1996","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.11.008_bib31","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0895-4356(00)00294-8","article-title":"Reliability, validity and responsiveness of general and disease-specific quality of life measures in a clinical trial for cytomegalovirus retinitis","volume":"54","author":"Martin","year":"2001","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ophtha.2006.11.008_bib32","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1097\/00005650-199108000-00011","article-title":"A heath status questionnaire using 30 items from the Medical Outcomes Study: preliminary validation in persons with early HIV infection","volume":"29","author":"Wu","year":"1991","journal-title":"Med Care"},{"key":"10.1016\/j.ophtha.2006.11.008_bib33","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"EuroQol\u2014a new facility for the measurement of health-related quality of life","volume":"16","year":"1990","journal-title":"Health Policy"},{"key":"10.1016\/j.ophtha.2006.11.008_bib34","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1128\/JCM.37.5.1431-1435.1999","article-title":"Comparison of cytomegalovirus loads in plasma and leukocytes of patients with cytomegalovirus retinitis","volume":"37","author":"Jabs","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ophtha.2006.11.008_bib35","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0197-2456(92)90027-W","article-title":"Studies of Ocular Complications of AIDS Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 1. Rationale, design and methods","volume":"13","year":"1992","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.ophtha.2006.11.008_bib36","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/00006982-200509000-00012","article-title":"Retinal vascular occlusion in patients infected with human immunodeficiency virus","volume":"25","author":"Dunn","year":"2005","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2006.11.008_bib37","series-title":"Practical Statistics for Medical Research","first-page":"213","author":"Altman","year":"1991"},{"key":"10.1016\/j.ophtha.2006.11.008_bib38","first-page":"20","article-title":"Table 20: reported cases of HIV infection (not AIDS) for male adults and adolescents, by transmission category and race\/ethnicity, cumulative through 2003\u201441 areas with confidential name-based HIV infection reporting","volume":"15","year":"2003","journal-title":"HIV AIDS Surveill Rep"},{"key":"10.1016\/j.ophtha.2006.11.008_bib39","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1093\/aje\/126.2.310","article-title":"The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants","volume":"126","author":"Kaslow","year":"1987","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ophtha.2006.11.008_bib40","unstructured":"Multicenter AIDS Cohort Study. Available at: http:\/\/www.statepi.jhsph.edu\/macs\/macs.html. Accessed October 18, 2006."},{"key":"10.1016\/j.ophtha.2006.11.008_bib41","unstructured":"National Institute of Allergy and Infectious Diseases. HIV infection among gay and bisexual men IX International Conference on AIDS highlights [sic]. Available at: http:\/\/www.aegis.com\/news\/niaid\/1993\/CDC93048.html. Accessed October 18, 2006."},{"key":"10.1016\/j.ophtha.2006.11.008_bib42","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1056\/NEJM198910263211701","article-title":"A prospective study of human immunodeficiency virus type 1 infection and the development of AIDS in subjects with hemophilia","volume":"321","author":"Goedert","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ophtha.2006.11.008_bib43","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1056\/NEJM200103083441003","article-title":"Initial plasma HIV-1 RNA levels and progression to AIDS in women and men","volume":"344","author":"Sterling","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ophtha.2006.11.008_bib44","unstructured":"National Institute of Allergy and Infectious Diseases. The Women and Infants Transmission Study. Available at: http:\/\/www.niaid.nih.gov\/daids\/wits.htm. Accessed October 18, 2006."},{"key":"10.1016\/j.ophtha.2006.11.008_bib45","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1086\/513929","article-title":"Behavioral and demographic risk factors for transmission of human immunodeficiency virus type 1 in heterosexual couples: report from the Heterosexual HIV Transmission Study","volume":"26","author":"Skurnick","year":"1998","journal-title":"Clin Inf Dis"},{"key":"10.1016\/j.ophtha.2006.11.008_bib46","unstructured":"National Institute of Allergy and Infectious Diseases. NIAID resources for studying HIV\/AIDS in women. Available at: http:\/\/www.aegis.com\/factshts\/niaid\/1997\/niaid97_fact_sheet_reswomen.html. Accessed October 18, 2006."},{"key":"10.1016\/j.ophtha.2006.11.008_bib47","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/01.qai.0000233310.90484.16","article-title":"Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study","volume":"43","author":"Palella","year":"2006","journal-title":"Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ophtha.2006.11.008_bib48","first-page":"1013","article-title":"The Women\u2019s Interagency HIV Study: an observational cohort brings clinical sciences to the bench","volume":"12","author":"Bacon","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.ophtha.2006.11.008_bib49","unstructured":"Veterans\u2019 Aging Cohort Study. Available at: http:\/\/www.vacohort.org. Accessed May 13, 2005."},{"key":"10.1016\/j.ophtha.2006.11.008_bib50","series-title":"Recruitment summary VACS\/NIAAA Study\u2014weekly report","year":"2006"},{"key":"10.1016\/j.ophtha.2006.11.008_bib51","doi-asserted-by":"crossref","first-page":"570","DOI":"10.7326\/0003-4819-130-7-199904060-00005","article-title":"Relations among CD4 lymphocyte nadir, antiretroviral therapy, and HIV-1 disease progression: results from the EuroSIDA Study","volume":"130","author":"Miller","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ophtha.2006.11.008_bib52","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.286.20.2560","article-title":"HIV viral load response to antiretroviral therapy according to the baseline CD4 cell count and viral load","volume":"286","author":"Phillips","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ophtha.2006.11.008_bib53","doi-asserted-by":"crossref","first-page":"17","DOI":"10.7326\/0003-4819-135-1-200107030-00005","article-title":"Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease","volume":"135","author":"Murphy","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ophtha.2006.11.008_bib54","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJM199907083410203","article-title":"Cytomegalovirus infection and HIV-1 disease progression in infants born to HIV-1 infected women","volume":"341","author":"Kovacs","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ophtha.2006.11.008_bib55","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0002-9394(14)71453-9","article-title":"Correlation between CD4+ counts and prevalence of cytomegalovirus retinitis and human immunodeficiency virus-related noninfectious retinal vasculopathy in patients with acquired immunodeficiency syndrome","volume":"115","author":"Kuppermann","year":"1993","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2006.11.008_bib56","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/infdis\/166.6.1223","article-title":"Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine","volume":"166","author":"Gallant","year":"1992","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ophtha.2006.11.008_bib57","first-page":"1069","article-title":"Risk of developing cytomegalovirus retinitis in persons infected with the human immunodeficiency virus","volume":"5","author":"Pertel","year":"1992","journal-title":"J Acquir Immune Defic Syndr"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016164200601548X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016164200601548X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:51:08Z","timestamp":1758981068000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016164200601548X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":57,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S016164200601548X"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2006.11.008","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Longitudinal Study of the Ocular Complications of AIDS","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2006.11.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}